Steven L. Dubovsky MD

Steven Dubovsky

Steven L. Dubovsky
MD

Professor and Chair; Department of Psychiatry, University at Buffalo and Adjoint Professor of Psychiatry and Medicine, University of Colorado School of Medicine

Department of Psychiatry

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Molecular and Cellular Biology; Neuropharmacology; Physiatrist; Psychiatry; Signal Transduction

Contact Information
University at Buffalo - Psychiatry
Erie County Medical Center
462 Grider St. Room 1168
Buffalo, New York 14215
Phone: 716-898-5940
Fax: 716-898-4538
dubovsky@buffalo.edu
View map


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD

Overview Research Publications Activities Latest News

Professional Summary:

Research Interests: Calcium Metabolism in Affective Disorders; Psychopharmacology; Psychosomatic Medicine; Medical Education. Clinical specialties: mood disorders, psychosis, interactions between medical and psychiatric disorders, psychopharmacology, difficult diagnoses, complex clinical entities

Education and Training:
  • Fellowship, Teaching Fellow (Chief Resident) in Psychiatry, University of Colorado (1973)
  • Residency, Psychiatry, University of Colorado Medical Center (1973)
  • Internship, Mixed Medical, Vancouver General Hospital (1970)
  • MD, Medicine, New York University School of Medicine (1969)
  • BA, New York University, Magna Cum Laude (1965)
  • Certification - American Board of Psychiatry and Neurology
  • Certification - Instructor, Advanced Cardiac Life Support
  • Certification - Provider, Advanced Cardiac Life Support
  • Certification- EMT-B
  • Certification- Instructor, Basic Life Support
  • Certification- Interior Firefighter
  • Certification- International Trauma Life Support
  • Certification- Peace Officer
  • Certification- Rescue Technician B

Employment:
  • Professor and Chair, Psychiatry, University at Buffalo, The State Univerity of New York Jacobs School of Medicine and Biomedical Sciences (2004-present)
  • Professor of Psychiatry and Medicine - Adjoint, University of Colorado School of Medicine (2004-present)
  • Visiting Professor, Department of Psychiatry, Cornell University, White Plains and New York (2009)
  • Visiting Professor, University of Massachusetts, Worcester, MA (2008)
  • Visiting Professor, University of New Mexico, Albuquerque (2007)
  • Advisory Board, Biovail (2005–2007)
  • Consultant, Invesco (2001–2004)
  • Vice Chair for Academic and Clinical Affairs, University of Colorado School of Medicine (2000–2004)
  • Consultant, Community Care Inc, Denver (1998–2004)
  • Consultant in Psychobiology, Boulder Community Hospital (1990–2004)
  • Professor of Psychiatry and Medicine, Psychiatry, University of Colorado School of Medicine (1989–2004)
  • Interim Superintendent, Colorado Psychiatric Hospital (1999–2001)
  • Medical Director, Colorado Psychiatric Hospital (1989–2001)
  • Vice Chairman for Clinical Affairs, Psychiatry, University of Colorado School of Medicine (1987–2001)
  • Interim Chair, Psychiatry, University of Colorado School of Medicine (1999–2000)
  • Attending Physician, Denver Veterans Administration Hospital (1979–1999)
  • Visiting Professor, Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba (1997)
  • Consultant in Psychobiology, Bethesda Psychiatric Center and Children/s Hospital, Denver Colorado (1991–1996)
  • Consulting Psychiatrist, Fitzsimons Army Hospital (1978–1996)
  • Consultant in Biological Psychiatry, Centennial Peaks Hospital (1985–1994)
  • Visiting Professor, Department of Psychiatry, University of Oklahoma, Tulsa (1993)
  • Visiting Professor, Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba (1992)
  • Acting Chairman, Psychiatry, University of Colorado School of Medicine (1991–1992)
  • Consultant to Perez Architects, Project to design a new airport for Denver (1988–1992)
  • Visiting Professor, Oregon Health Sciences University and Oregon Department of Human Resources, Portland (1991)
  • Consultant in Psychobiology, Mt. Airy Hospital, Denver (1987–1991)
  • Noland Lewis Visiting Professor, Department of Psychiatry, Carrier Foundation, Princeton, NJ (1989)
  • Associate Director, Colorado Psychiatric Hospital (1986–1989)
  • Associate Professor of Psychiatry and Medicine, University of Colorado School of Medicine (1983–1989)
  • Associate Professor of Psychiatry, University of Colorado School of Medicine (1979–1989)
  • Consultant, U. S. Administrators (1984–1988)
  • Director of Clinical Affairs, Psychiatry, University of Colorado School of Medicine (1986–1987)
  • Distinguished Visiting Professor of Psychiatry, Department of Psychiatry, University of Texas and Wilford Hall Medical Center, San Antonio (1986)
  • Visiting Professor, Department of Psychiatry, West Virginia University (1985)
  • Visiting Professor, Department of Psychiatry, Wright State University (1985)
  • Associate Dean for Faculty Affairs, University of Colorado School of Medicine (1984–1985)
  • Acting Dean, University of Colorado School of Medicine (1984)
  • Distinguished Visiting Professor of Psychiatry, University of Texas and Wilford Hall Medical Center, San Antonio (1984)
  • Visiting Professor, Departments of Psychiatry, University of Oregon and Good Samaritan Hospital Portland, Oregon (1984)
  • Associate Dean for Academinc and Faculty Affairs, University of Colorado School of Medicine (1983–1984)
  • Visiting Lecturer in Psychiatry, Cornell University School of Medicine (1983–1984)
  • Associate Dean for Academic Affairs, University of Colorado School of Medicine (1982–1983)
  • External Examiner in Psychiatry and Internal Medicine, King Saud University, Riyadh, Saudi Arabia (1982)
  • Visiting Professor, Department of Psychiatry, University of Manitoba Medical School Winnipeg, Canada (1982)
  • Associate Dean for Student Affairs, University of Colorado School of Medicine (1979–1982)
  • Associate Director, General Clinical Research Center (1978–1981)
  • Distinguished Visiting Professor of Psychiatry, Department of Psychiatry, University of Texas, San Antonio (1979)
  • Director of Undergraduate Education in Psychiatry, University of Colorado School of Medicine (1977–1979)
  • Assistant Professor of Psychiatry, University of Colorado School of Medicine (1974–1979)
  • Moderator, Psychiatry Sections, Family Practice Review, University of Colorado Medical Center (1974–1978)
  • Consultant to Student Advisory Office, University of Colorado Medical Center (1974–1977)
  • Consulting Psychiatrist, General Medical Outpatient Clinic, University Hospital (1974–1976)
  • Consulting Psychiatrist, Department of Medical Education, Presbyterian Hospital (1975)
  • Consultant, Colorado Non-Psychiatric Physicians Group (1973–1975)
  • Instructor in Psychiatry, University of Colorado School of Medicine (1973–1974)
  • Attending Physician, University Hospital (1973)
  • Attending Psychiatrist, Colorado Psychiatric Hospital (1973)
  • Consultant, Billings Area Indian Health Service (1972–1973)
  • Consultant, Ft. Collins Welfare System (1970–1971)
  • Director, Lower East Side Student Health Organization (1963–1965)
  • Director, Lower East Side Student Health Project (1963)
  • Member, California Student Health Project (1962)
  • Assistant Teacher, Operation Headstart (1961)
  • Counselor, Childville, (residential treatment center for disturbed children) - Bedford Stuyvesant (1960)
See all (54 more)

Awards and Honors:
  • Listed in International Who's Who in Medicine (2022)
  • Listed in Who’s Who in Medicine and Healthcare (2022)
  • Listed in Castle Connolly Top Doctors (2022)
  • Listed in Who's Who in America (2022)
  • Listed in Who's Who in the World (2022)
  • Listed in The Best Doctors in America (2022)
  • Listed in Who’s Who (2022)
  • Chancellor’s Award for Faculty Service (2020)
  • Western New York’s Top Doctors (2020)
  • Listed in Top Psychiatrists (2019)
  • Listed in US News Top Doctors, 2017-2019 (2019)
  • Lifetime Achievement Award (2019)
  • Listed in Who’s Who of Prominent Innovators and Achievers (2017)
  • UB Exceptional Scholar (2011)
  • Listed in Who’s Who in Healthcare 2010 (2010)
  • Award for Outstanding Contributions to Medical Student Education (2009)
  • Dean’s Award, University at Buffalo (2007)
  • Nancy D. Smith Memorial Award “In recognition of your compassionate and enlightened service to the most vulnerable among us” (2005)
  • Community Service Award (2005)
  • National Alliance for the Mentally Ill in Buffalo and Erie County, 2005 (2005)
  • Outstanding Achievement Award Colorado Psychiatric Society (2004)
  • 21st Gold Medal Award for Distinction and Excellence in Psychiatry. (1991)
  • Ninth Eleanor Steele Award for Inspirational Teaching and Supervision. (1990)
  • Listed in Top Doctors in Denver (5280 Magazine)
  • Listed in Personalities of the Americas
  • Listed in Men of Achievement
  • Listed in International Who's Who of Intellectuals
  • Listed in Who's Who of Emerging Leaders in America
  • Listed in Who’s Who in American Education
  • Listed in International Directory of Distinguished Leadership
  • Listed in America’s Top Psychiatrists
  • Listed in Who's Who in the West

Research Expertise:
  • Children and Adults; Psychiatry: Research Interests: Calcium Metabolism in Affective Disorders; Psychopharmacology; Psychosomatic Medicine; Medical Education. Clinical specialties: mood disorders, psychosis, interactions between medical and psychiatric disorders, psychopharmacology, difficult diagnoses, complex clinical entities.

UB 2020 Strategic Strengths:
  • Extreme Events: Mitigation and Response
  • Health and Wellness Across the Lifespan

Grants and Sponsored Research:
  • December 2022–December 2025
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia
    Neurocrine
    Role: Principal Investigator
  • December 2022–December 2024
    A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated with Bipolar I Disorder (Bipolar I Depression)
    Sunovion
    Role: Principal Investigator
  • December 2022–December 2024
    A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated with Bipolar I Disorder (Bipolar I Depression)
    Sunovion
    Role: Principal Investigator
  • August 2022–October 2024
    A 2-Part Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) Administered to Adults with Major Depressive Disorder at Imminent Risk of Suicide
    Seelos
    Role: Principal Investigator
  • January 2021–December 2023
    A 26-week, Multicenter, Open-label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia or Bipolar I Disorder (3070-30-001), Abbvie
    Abbvie
    Role: Principal Investigator
    $150,000
  • January 2021–December 2023
    A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12 week treatment period in patients with borderline personality disorder, Boehringer Ingelheim
    Boehringer Ingelheim
    Role: Principal Investigator
    $200,000
  • July 2022–January 2023
    A Prospective, multicenter, randomized controlled blinded trial demonstrating the safety and effectiveness of VNS therapy as adjunctive therapy versus a no stimulation control in subjects with treatment-resistant depression
    Medicare
    Role: Co-Investigator
  • January 2019–December 2021
    A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 years of age) with Schizophrenia Allergan
    Allergan
    Role: Principal Investigator
    $200,000
  • January 2018–December 2021
    A phase II randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period as an early intervention in patients with attenuated psychosis syndrome. Boehringer Ingelheim
    Boehringer Ingelheim
    Role: Principal Investigator
    $125,000
  • January 2018–December 2021
    A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo- Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects with Cognitive Impairment Associated with Schizophrenia, Biogen
    Biogen
    Role: Principal Investigator
    $125,000
  • January 2018–December 2020
    A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with schizophrenia.
    Boehringer Ingelheim
    Role: Principal Investigator
    $100,000
  • January 2018–December 2020
    A multi-centre, double-blind, parallel-group, randomized controlled study to investigate efficacy and safety of orally administered BI 425809 during a 12-week treatment period compared to placebo in patients with cognitive impairment due to Alzheimer’s Disease
    Boehringer Ingelheim
    Role: Principal Investigator
    $150,000
  • January 2018–December 2020
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Episodes Associated with Bipolar I or Bipolar II Disorder (Bipolar Depression)
    Intra-Cellular Therapies
    Role: Principal Investigator
    $125,000
  • January 2017–January 2019
    A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intranasal esketamine in addition to comprehensive standard of care for the rapid reduction of the symptoms of major depressive disorder, including suicidal ideation, in adult subjects assessed to be at imminent risk for suicide.
    Janssen Research and Development
    Role: Principal Investigator
    $188,000
  • January 2017–January 2019
    Real-world Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents (RE-Kinect Study).
    Neurocrine Biosciences
    Role: Principal Investigator
    $75,000
  • January 2017–January 2019
    A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of 3 fixed doses (28 mg, 56 mg and 84 mg) of intranasal esketamine in addition to comprehensive standard of care for the rapid reduction of the symptoms of major depressive disorder, including suicidal ideation, in pediatric subjects assessed to be at imminent risk for suicide (ESKETINSUI2002)
    Janssen Research & Development
    Role: Co-Investigator
  • January 2017–January 2019
    A Randomized, Multicenter, Crossover Study to Assess the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Subjects With Major Depressive Disorder (NOPRODMDD0003; Revere.D)
    Janssen Research and Development
    Role: Principal Investigator
    $150,000
  • January 2017–January 2019
    A Phase 3, Randomized, double-blind, placebo-controlled, parallel-group, multicenter, fixed-dose clinical trial evaluating the efficacy, safety and tolerability of cariprazine in patients with bipolar I depression
    Allergan
    Role: Principal Investigator
    $200,000
  • January 2016–January 2018
    Randomized, double-blind, parallel-group, placebo-controlled, dose ranging study of piromelatine in patients with mild dementia due to Alzheimer’s disease.
    Neurim Pharmaceuticals
    Role: Principal Investigator
    $150,000
  • January 2015–January 2018
    Phase 3, open-label, safety and tolerability study of NBI-98854 for the treatment of tardive dyskinesia.
    Neurocrine Biosciences
    Role: Principal Investigator
    $188,276
  • January 2015–January 2018
    Open-label, long-term safety study of vilazodone in pediatric patients with major depressive disorder.
    Forest Research Institute
    Role: Principal Investigator
    $221,000
  • January 2015–January 2017
    Randomized, double-blind, placebo-controlled, phase 4 relapse prevention study evaluating the efficacy and safety of vortioxetine (5, 10,, & 20 mg) in adults with major depressive disorder.
    Takeda Development Center
    Role: Principal Investigator
    $135,530
  • January 2015–January 2017
    Access to Psychiatry Through Intermediate Care (APIC)
    Tower Foundation
    Role: Principal Investigator
    $1,300,000
  • January 2014–January 2016
    An innovative integrated mental health service delivery system.
    Wendt Foundation
    Role: Principal Investigator
    $150,000
  • January 2014–January 2016
    A novel service delivery model for mentally ill adults.
    Patrick Lee Foundation
    Role: Principal Investigator
    $150,000
  • January 2014–January 2016
    A Phase 3, 12-week, multicenter, randomized, double-blind, placebo controlled trial to evaluate the efficacy, safety, and tolerability of flexible dosing of brexpiprazole (OPC 34712) in the treatment of subjects with agitation associated with dementia
    Otsuka
    Role: Principal Investigator
    $200,000
  • January 2014–January 2016
    Integrated service delivery for Western New York.
    Oshei Foundation
    Role: Principal Investigator
    $200,000
  • January 2013–January 2016
    A Phase III, multi-center, randomized, 24 week, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsycho
    Role: Principal Investigator
    $200,000
  • January 2013–January 2015
    A 2-month,Observational Rollover Trial to Evaluate the Safety of Subjects w/ Agitation Associated with Dementia of the Alzheimer’s Type who were Previously Treated with Brexpiprazole (OPC-34712) or Placebo in a Phase 3, Double-blind Trial (331-13-211)
    Takeda
    Role: Principal Investigator
    $150,000
  • January 2011–January 2015
    A multicenter, open-label study to assess hospitalization rates in adult subjects with schizophrenia treated prospectively for 6 months with aripiprazole IM depot compared with 6-month retrospective treatment with oral antipsychotic in a naturalistic com
    Otsuka
    Role: Principal Investigator
    $150,000
  • January 2013–December 2014
    A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety and tolerability of desvenlafaxine succinate sustained-release (DVS SR) in the treatment of children and adolescent outpatients with major
    Role: Principal Investigator
    $150,000
  • January 2013–January 2014
    Virtual reality model of an emergency room- proof of concept. Research for Health in Erie County
    Role: Principal Investigator
    $45,000
  • January 2012–January 2014
    A 52-week, multicenter, randomized, double-blind, placebo controlled study to evaluate the efficacy, safety, and tolerability of an intramuscular depot formulation of aripiprazole (OPC-14597) as maintenance treatment in patients with bipolar I disorder.
    Role: Principal Investigator
    $150,000
  • January 2012–January 2014
    A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance treatment of subjects with schizophrenia (D1050238). Sunovion
    Role: Principal Investigator
    $200,000
  • January 2011–January 2014
    A long-term, Phase 3, multicenter, open-label trial to evaluate the safety and tolerability of oral OPC-34712 as maintenance treatment in adults with schizophrenia. Otsuka
    Role: Principal Investigator
    $150,000
  • January 2011–January 2014
    A long-term, multicenter, open-label study to evaluate the safety and tolerability of flexible-dose oral aripiprazole (OPC-14597) as maintenance treatment in adolescent patients with schizophrenia or child and adolescent patients with bipolar I disorder,
    Otsuka
    Role: Principal Investigator
    $150,000
  • January 2011–January 2013
    A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot compared with 6-month Retrospective Treatment with Oral Antipsychotics in a Naturalistic Co
    Otskuka
    Role: Principal Investigator
    $200,000
  • January 2011–January 2013
    A Phase 3, multicenter, double-blind, placebo-controlled study of 3 doses of LY2140023 monohydrate in the acute treatment of patients with DSM-IV-TR schizophrenia. Lilly
    Lilly
    Role: Principal Investigator
    $174,000
  • January 2011–January 2013
    A Fifteen-Month, Prospective, Randomized, Active-Controlled, Open-Label, Flexible-Dose Study of Paliperidone Palmitate Compared with Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults with Schizophrenia Who Have Been Incarcerate
    Janssen
    Role: Principal Investigator
    $74,000
  • January 2011–January 2013
    A fifteen-month, prospective, randomized, active-controlled, open-label, flexible-dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia. Ortho McNeil Janssen
    Ortho McNeil Janssen
    Role: Principal Investigator
    $150,000
  • January 2011–January 2013
    A 6-month, open-label,multicenter, flexible-dose extension study to the B2061032 study to evaluate the safety, tolerability &efficacy of desvenlafaxine succinate sustained-release (dvs sr) tablets in the treatment of children & adolescent patient. Pfizer
    Role: Principal Investigator
    $200,000
  • January 2010–January 2013
    A long-term, multicenter, open-label study to evaluate the safety and tolerability of flexible-dose oral aripiprazole (OPC-14597) as maintenance treatment in adolescent patients with schizophrenia (31-09-267). Otsuka:
    Role: Principal Investigator
    $150,000
  • January 2010–January 2013
    Open-label, multicenter, rollover, long-term study of aripiprazole intramuscular depot in patients with schizophrenia (31-10-270). Otsuka:
    Role: Principal Investigator
    $150,000
  • January 2011–January 2012
    A Phase III, multi-center, randomized, 12 week, double-blind, parallel group, placebo-controlled study to evaluate efficacy and safety of R04917838 in patients with sup-optimally controlled symptoms of schizophrenia. Genotech
    Role: Principal Investigator
    $150,000
  • January 2011–January 2012
    A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inade
    Astra Zeneca
    Role: Principal Investigator
    $75,000
  • January 2011–January 2012
    A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia. Lilly
    Role: Principal Investigator
    $645,000
  • January 2011–January 2012
    A phase 3, long-term, open-label, flexible dose, extension study evaluating the safety and tolerability of LuAA21004 (15 and 20mg) in subjects with major depressive disorder. Takeda
    Role: Principal Investigator
    $175,000
  • January 2010–January 2012
    A Randomized Phase 2A, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of CP-601,927 Augmentation of Antidepressant Therapy in Major Depression (A3331017). Pfizer
    Role: Principal Investigator
    $150,000
  • January 2010–January 2012
    Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subjects with Euvolemic Hyponatremia (CK-LX3405). Cardiokine
    Role: Principal Investigator
    $75,000
  • January 2010–January 2012
    International, multicenter, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: Extension to studies CK-LX3401, 3405, and 3430 (CK-LX3431). Cardiokine
    Role: Principal Investigator
    $150,000
  • January 2008–January 2012
    Rapid Pediatric Psychiatry Consultation Project. Tower Foundation
    Role: Principal Investigator
    $400,000
  • January 2010–January 2011
    Randomized phase 2A, double-blind, placebo-controlled study of the efficacy and safety of CP-601,927 augmentation of antidepressant therapy in major depression. Pfizer
    Pfizer
    Role: Principal Investigator
    $100,000
  • January 2010–January 2011
    Four week, double-blind, placebo controlled phase III trial evaluating the efficacy, safety and pharmacokinetics of flexible doses of oral ziprasidone in children and adolescents with bipolar I disorder. Pfizer
    Pfizer
    Role: Principal Investigator
    $75,000
  • January 2010–January 2011
    A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit
    Astra Zeneca
    Role: Principal Investigator
    $100,000
  • January 2008–December 2010
    Phase III, randomized, placebo-controlled clinical trial to study the safety and efficacy of 3 doses of lurasidone in acutely psychotic patients with schizophrenia. Sumitomo Pharma
    Role: Principal Investigator
    $250,000
  • January 2009–January 2010
    Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of oral lixivaptan capsules in subjects with euvolemic hyponatremia.
    Cardiokine
    Role: Principal Investigator
    $75,000
  • January 2009–January 2010
    Antidepressant impact of lurasidone in bipolar depression.
    Sumitomo Pharma
    Role: Principal Investigator
    $250,000
  • January 2008–January 2010
    A 52-week, multicenter, double-blind, placebo-controlled study to evaluate the safety, efficacy and tolerability of an intramuscular depot formulation of aripiprazole as maintenance treatment in patients with schizophrenia Otsuka
    Role: Principal Investigator
    $125,000
  • January 2008–December 2009
    A 12-week, multicenter, open label study to evaluate the effectiveness and safety of donepezil hydrochloride (E2020) in subjects with mild to severe Alzheimer’s disease residing in an assisted living facility. Esai
    Role: Principal Investigator
    $150,000
  • January 2008–December 2009
    Comparison of divalproex plus olanzapine or placebo in mild to moderate mania. Lilly
    Role: Principal Investigator
    $83,920
  • January 2007–January 2009
    A randomized, parallel group, multiple dose six-week study to evaluate safety, tolerability and pharmacokinetics of asenapine in elderly patients. Merck
    Role: Principal Investigator
    $150,000
  • January 2008–December 2008
    A multicenter, double-blind, flexible-dose, 6-month trial comparing the efficacy and safety of asenapine and olanzapine in stable subjects with persistent negative symptoms of schizophrenia. Pfizer
    Role: Principal Investigator
    $100,000
  • January 2007–December 2008
    A 52-week, randomized, double-blind, placebo-controlled, multi-center, parallel-group study of the long-term efficacy, tolerability and safety of agomelatine 25 and 50 mg in the prevention of relapse of Major Depressive Disorder (MDD) following open-labe
    Role: Principal Investigator
    $200,000
  • January 2007–December 2008
    A three-week double-blind, multicenter, placebo controlled study evaluating the safety and efficacy of add-on ziprasidone to lithium or divalproex in mania. Pfizer
    Role: Principal Investigator
    $60,000
  • January 2006–December 2008
    Efficacy of psychiatric consultation to pediatricians treating mental disorders. Tower Foundation:
    Role: Principal Investigator
    $100,000
  • January 2006–December 2007
    A Randomized, Parallel-Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects with Psychosis. Janssen:
    Role: Principal Investigator
    $200,000
  • January 2006–December 2007
    A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine with Olanzapine in Stable Subjects with Predominant, Persistent Negative Symptoms of Schizophrenia. Pfizer:
    Role: Principal Investigator
    $150,000
  • January 2006–December 2007
    A Phase 3, Randomized, 6-Month, Double Blind Trial in Subjects with Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus Mood Stabilizer (vs. Placebo Plus a Mood Stabilizer) Following a Minimum of 4 Months Res
    Role: Principal Investigator
    $250,000
  • January 2006–December 2007
    Ziprasidone for adolescent mania. Pfizer
    Pfizer
    Role: Principal Investigator
    $210,000
  • January 2005–December 2006
    Open-label, flexible-dose, long-term safety and efficacy study of bifeprunox in the treatment of schizophrenia. Solvay
    Role: Principal Investigator
    $100,000
  • January 2005–December 2006
    Extended release memantine in moderate-severe Alzheimer‘s disease. Forest
    Role: Principal Investigator
    $200,000
  • January 2005–December 2005
    Randomized, double-blind, placebo-controlled and risperidone-referenced parallel group efficacy and safety study of two fixed doses of bifeprunox in the treatment of schizophrenia. Solvay
    Role: Principal Investigator
    $150,000
  • January 2005–December 2005
    Does levetiracetam lower platelet intracellular calcium ion concentration in bipolar mood disorder? UCB Pharma
    Role: Principal Investigator
    $50,000
  • January 2004–December 2005
    Aripiprazole in refractory depression. BMS
    Role: Principal Investigator
    $100,000
  • January 2001–December 2005
    NIDA Clinical Trials Network (Paula Riggs, P.I.):
    Role: Principal Investigator
  • January 2005–January 2005
    Bipolar Disorder in Primary Care
    Role: Principal Investigator
  • January 2004–December 2004
    Paloperidone for schizophrenia. Johnson and Johnson.
    Role: Principal Investigator
    $250,000
  • January 2004–December 2004
    Prediction of Psychiatric Diagnosis with Brain Imaging Using SPECT. Brain Matters
    Role: Principal Investigator
    $50,000
  • January 2003–December 2004
    Neuramaxane plus donepezil in Alzheimer‘s disease. Forest
    Role: Principal Investigator
    $250,000
  • January 2003–December 2004
    Levatiracetam effect on intracellular calcium signaling in bipolar disorder. Pharma
    Role: Principal Investigator
    $50,000
  • January 2003–December 2003
    Escitalopram for pediatric depression. Forest:
    Role: Principal Investigator
    $150,000
  • January 2002–December 2003
    Evaluation of patients with bipolar disorder. Sutherland Foundation
    Role: Principal Investigator
    $49,000
  • January 2002–December 2003
    Memantine plus donepezil in Alzheimer‘s disease. Forest
    Role: Principal Investigator
    $250,000
  • January 2002–December 2003
    MK-1 antagonist for major depression. Merck
    Role: Principal Investigator
    $293,000
  • January 2001–December 2003
    Memantine in Alzheimer‘s disease. Forest
    Role: Principal Investigator
    $200,000
  • January 2001–December 2002
    Galantamine in Lewy body disease. Janssen
    Role: Principal Investigator
    $150,000
  • January 2001–December 2002
    Galantamine in Alzheimer’s disease. Janssen
    Role: Principal Investigator
    $100,000
  • January 2001–December 2002
    Valproic acid for agitation in demented nursing home patients. Abbott Laboratories
    Role: Principal Investigator
    $100,000
  • January 2001–December 2002
    Ariprazole for psychosis in demented nursing home patients. Bristol Myers Squibb
    Role: Principal Investigator
    $150,000
  • January 2000–December 2001
    Outpatient trial of sertraline in children and adolescents with major depressive disorder. Pfizer
    Role: Co-Investigator
    $97,000
  • January 2000–December 2001
    5HT1D antagonist in panic disorder. Pfizer
    Role: Principal Investigator
    $150,000
  • January 2000–December 2001
    CP-448 (5HT1D antagonist) in major depressive disorder. Pfizer
    Role: Principal Investigator
    $150,000
  • January 1999–December 2000
    Extended study of pregabalin for social phobia. Parke-Davis
    Role: Principal Investigator
    $279,000
  • January 1999–December 2000
    Fluvoxamine in social phobia. Solvay
    Role: Principal Investigator
    $79,000
  • January 1999–December 2000
    L-deprenyl patch for depression. Somerset
    Role: Principal Investigator
    $109,000
  • January 1999–December 2000
    Injectible olanzapine versus placebo in the treatment of acute mania. Eli Lilly
    Role: Principal Investigator
    $160,000
  • January 1999–December 2000
    Olanzapine versus risperidone in the treatment of agitation and psychosis in demented patients. Lilly
    Role: Principal Investigator
    $150,000
  • January 1999–December 2000
    Somatostatin analogue in Alzheimer‘s disease. Fugisawa
    Role: Principal Investigator
    $250,000
  • January 1998–December 1999
    Pregabalin for generalized anxiety disorder. Parke-Davis
    Role: Principal Investigator
    $400,000
  • January 1998–December 1999
    Prevalence of hyperprolactinemia in schizophrenic patients treated with antipsychotic drugs. Eli Lilly
    Role: Principal Investigator
    $24,000
  • January 1998–December 1999
    Substance P inhibitor for major depressive disorder. Novartis
    Role: Principal Investigator
    $250,000
  • January 1998–December 1999
    Substance P inhibitor for social phobia. Novartis
    Role: Principal Investigator
    $250,000
  • January 1998–December 1999
    Placebo Controlled Study of Two Doses of Fluoxetine in Post Traumatic Stress Disorder. Eli Lilly
    Role: Principal Investigator
    $230,000
  • January 1998–December 1999
    Placebo controlled trial of paroxetine in post traumatic stress disorder. Smith Kline
    Role: Principal Investigator
    $200,000
  • January 1998–December 1999
    Placebo-Controlled Study of Pregabalin and Lorazepam in Patients with Generalized Anxiety Disorder. Parke-Davis Research
    Role: Principal Investigator
    $456,000
  • January 1998–December 1999
    Olanzapine versus risperidone and placebo in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Eli Lilly
    Role: Principal Investigator
    $115,700
  • January 1998–December 1999
    Olanzapine in the Reduction of Hyperprolactinermia and associated morbidity in schizophrenic
    Role: Principal Investigator
    $26,500
  • January 1998–December 1998
    Metrifonate for Alzheimer’s disease: MINT study. Bayer Laboratories
    Role: Principal Investigator
    $30,000
  • January 1998–December 1998
    Sertraline in Post Traumatic Stress Disorder. Pfizer Laboratories
    Role: Principal Investigator
    $298,000
  • January 1998–December 1998
    Sertraline in Premenstrual Syndrome. Pfizer Laboratories
    Role: Principal Investigator
    $62,000
  • January 1997–December 1998
    Exelon for Alzheimer’s Disease, Novartis
    Role: Principal Investigator
    $200,000
  • January 1996–December 1997
    E2020 (Donepezil) in Alzheimer’s Disease, Esai/Pfizer Laboratories
    Role: Principal Investigator
    $260,000
  • January 1994–December 1995
    Metrifonate in Alzheimer‘s disease, Miles Laboratories
    Role: Principal Investigator
    $375,000
  • January 1994–December 1995
    Physostigmine Extended Release in Alzheimer‘s disease, Forrest
    Role: Principal Investigator
    $320,000
  • January 1988–December 1990
    Nimodipine in Alzheimer‘s disease, Miles Laboratories
    Role: Principal Investigator
    $220,000
  • January 1979–December 1982
    5-D18-MB0035 BHM HRA
    BHM HRA
    Role: Principal Investigator
    $492,000
  • January 1977–December 1982
    MH l45l7, NIMH
    Role: Principal Investigator
    $255,000
  • December 2022
    67953964MDD3002: A Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
    Role: Principal Investigator
  • April 2022
    A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia (CONNEX-1) (1346-0011)
    Role: Principal Investigator
See all (109 more)

Journal Articles:

See all (152 more)

Books and Book Chapters:

  • Dubovsky SL Marshall D. (2022) Barbiturates and similarly acting substances. In: Kaplan & Sadock: Comprehensive Textbook of Psychiatry, 11th Ed. Wolters Kluwer
  • Dubovsky SL Marshall D. (2022) Benzodiazepine agonists and antagonists. In: Kaplan & Sadock: Comprehensive Textbook of Psychiatry, 11th Ed. Wolters Kluwer
  • Dubovsky SL Marshall D. (2022) Calcium channel inhibitors. In: Kaplan & Sadock: Comprehensive Textbook of Psychiatry, 11th Ed. Wolters Kluwer
  • Dubovsky SL. (2017) Comprehensive Textbook of Psychiatry, 10th Ed. In: (In Press) Barbiturates and similarly acting substances In: Sadock BJ, Sadock VA. LWW
  • Dubovsky SL. (2017) Comprehensive Textbook of Psychiatry, 10th Ed. In: (In Press) Benzodiazepine receptor agonists and antagonists. In: Sadock BJ, Sadock VA.
  • Dubovsky SL. (2017) Comprehensive Textbook of Psychiatry, 10th Ed. In: (In Press) Calcium channel inhibitors. In: Sadock BJ, Sadock VA:. LWW
  • Dubovsky SL. (2013) Behavioral Neurology and Neuropsychiatry. In: Pharmacotherapy of emotional disturbances. In: Arciniegas DB, Anderson A, Filley C: Behavioral Neurology and Neuropsychiatry. Cambridge University Press, 543-565.
  • Dubovsky SL, Dubovsky AN. (2011) Textbook of Geriatric Neuropsychiatry. In: Geriatric neuropsychopharmacology. In: Coffey E, Cummings J: Textbook of Geriatric Neuropsychiatry. American Psychiatric Press, 237-276.
  • Dubovsky SL, Warren CG. (2010) Clinical Challenges in Hypertension. In: Are anxiety and panic related to hypertension? in: Toth PP, Sica DA: Clinical Challenges in Hypertension. Atlas Medical Publishing, 1-11.
  • Dubovsky SL. (2009) Comprehensive Textbook of Psychiatry, 9th Ed. In: Barbiturates and related drugs. In: Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry, 9th Ed. Williams and Wilkins, 3038-3043.
  • Dubovsky SL. (2009) Comprehensive Textbook of Psychiatry 9th Ed. In: Calcium channel inhibitors. In:Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry 9th Ed. Williams and Wilkins, 3065-3072.
  • Dubovsky SL. (2009) Hypertension Primer, 4th Ed. In: Hypertension and psychiatric disorders. In Izzo JL, Sica DA, Black HR (eds): Hypertension Primer, 4th Ed. Lippincott Williams and Wilkins, 545-549.
  • Dubovsky SL. (2009) Comprehensive Textbook of Psychiatry, 9th Ed. In: Drugs acting on the benzodiazepine receptor. In: Sadock BJ, Sadock VA, Ruiz P: Comprehensive Textbook of Psychiatry, 9th Ed. Williams and Wilkins, 3044-3055.
  • Arciniegas DE, Dubovsky SL. (2007) Treatments of Psychiatric Disorders. In: Dementia due to other general medical conditions and demential due to multiple etiologies. In: Gabbard GO(ed): Treatments of Psychiatric Disorders. American Psychiatric Press, 159-178.
  • Wolin R., Dubovsky SL, Cowan RB. (2007) Neurology and Internal Medicine. In: Depression and neurology. In: Biller J (ed): Neurology and Internal Medicine. Lippincott Williams and Wilkins, 949-957.
  • Dubovsky SL. (2007) Psychotropic Drug Prescriber‘s Survival Guide: How to Practive Ethically in the Era of Big Pharma. WW Norton.
  • Dubovsky SL. (2005) Clinical Guide to Psychotropic Medications. WW Norton.
  • Dubovsky SL. (2004) Comprehensive Textbook of Psychiatry VIII. In: Calcium channel inhibitors. In: Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry VIII. Williams and Wilkins, 2801-2807.
  • Dubovsky SL. (2004) Comprehensive Textbook of Psychiatry VIII. In: Agents acting on the benzodiazepine receptor. In: Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry VIII. Williams and Wilkins, 2781-2790.
  • Dubovsky SL, Dubovsky AN. (2002) Concise Guide to Mood Disorders. American Psychiatric Press, Inc..
  • Maxmen JS, Ward NG, Dubovsky SL(special consultant). (2002) Psychotropic Drugs Fast Facts, Third Edition. WW Norton.
  • Dubovsky SL, Davies R, Dubovsky AN. (2002) American Psychiatric Press Textbook of Psychiatry. In: Mood Disorders. In: Hales RE, Yudofsky SC, Talbott JA: American Psychiatric Press Textbook of Psychiatry. American Psychiatric Press, 439-542.
  • Arcinegas D, Dubovsky SL. (2001) Treatment of Psychiatric Disorders (3rd Ed). In: Other Forms of Dementia. In: Gabbard GO(ed): Treatment of Psychiatric Disorders (3rd Ed). American Psychiatric Press, 555-575.
  • Dubovsky SL, Buzan R. (2000) Textbook of Geriatric Neuropsychiatry. In: Psychopharmacology. In: Coffee CE, Cummings JL: Textbook of Geriatric Neuropsychiatry. American Psychiatric Press, 779-828.
  • Dubovsky SL. (1999) Encyclopedia of Human Emotions. In: Mind, Body and Mood> In: Levinson D, Ponzetti J, Jorgensen P (eds): Encyclopedia of Human Emotions. Macmillan, 551-597.
  • Dubovsky SL, Buzan RD. (1999) American Psychiatric Press Textbook of Psychiatry. In: Mood Disorders. In: Hales RE, Yudofsky SC, Talbott JA: American Psychiatric Press Textbook of Psychiatry. American Psychiatric Press, 479-565.
  • Dubovsky SL. (1998) American Psychiatric Press Textbook of Psychopharmacology (2nd edition). In: Dubovsky SL: Calcium channel antagonists as novel treatments for manic depressive disorder. In: Schatzberg AF, Nemeroff CB (eds): American Psychiatric Press Textbook of Psychopharmacology (2nd edition). American Psychiatric Press, 455-469.
  • Dubovsky SL. (1997) Mind-Body Deceptions. WW Norton.
  • Dubovsky SL. (1996) Psychiatry (3rd Ed.). In: Anxiety Disorders. In. Scully JH (ed):Psychiatry (3rd Ed.). Lippincott, 101-118.
  • Dubovsky SL, Thomas M. (1996) Practical Clinical Strategies in Treating Depression and Anxiety in a Managed Care Environment. In: Concepts and treatment strategies for double depression. In: Hales RE, Yudofsky SC (eds): Practical Clinical Strategies in Treating Depression and Anxiety in a Managed Care Environment. American Psychiatric Press, 26-33.
  • Dubovsky SL. (1996) Psychiatry (3rd Ed.). In: Substance-Related Disorders. In: Scully JH (ed): Psychiatry (3rd Ed.). Lippincott, 141-166.
  • Dubovsky SL. (1995) Psychiatry (Second Edition). In: Substance-Related Disorders. In: Scully JH (ed): Psychiatry (Second Edition). Williams and Wilkins, 141-166.
  • Dubovsky SL. (1995) Treatment of Psychiatric Disorders, Second Edition. In: Dementia due to other general medical conditions and dementia due to multiple etiologies. In: Gabbard GO (ed): Treatment of Psychiatric Disorders, Second Edition. American Psychiatric Press, 535-574.
  • Dubovsky SL, Butler LD. (1995) Casebook and Study Guide. Abnormal Psychology, Third Edition. WW Norton.
  • Dubovsky SL. (1995) American Psychiatric Press Textbook of Psychopharmacology. In: Calcium channel antagonists as novel treatments for manic depressive disorder. In: Schatzberg AF, Nemeroff CB (eds): American Psychiatric Press Textbook of Psychopharmacology. American Psychiatric Press, 377-390.
  • Dubovsky SL. (1995) Psychiatry (Second Edition). In: Anxiety Disorders. In: Scully JH (ed): Psychiatry (Second Edition). Williams and Wilkins, 101-117.
  • Dubovsky SL. (1994) Comprehensive Textbook of Psychiatry. Sixth Edition, Volume 2. In: Electroconvulsive therapy. In: Kaplan H, Sadock B (eds): Comprehensive Textbook of Psychiatry. Sixth Edition, Volume 2. Williams and Wilkins, 97-112.
  • Dubovsky SL. (1994) Textbook of Geriatric Neuropsychiatry. In: Geriatric neuropsychopharmacology. In: Coffey CE, Cummings JL (eds): Textbook of Geriatric Neuropsychiatry. American Psychiatric Press, 595-632.
  • Dubovsky SL. (1991) Textbook of Neuropsychiatry (Second Edition). In: Psychopharmacologic treatment in neuropsychiatry. In: Hales RE, Yudofsky SC (eds): Textbook of Neuropsychiatry (Second Edition). American Psychiatric Press, 663-701.
  • Dubovsky SL, Shore JH (eds). (1989) Current Therapy in Psychiatry. CV Mosby (in press).
  • Dubovsky SL. (1988) Concise Guide to Clinical Psychiatry. American Psychiatric Press, Inc..
  • Dubovsky SL. (1988) Psychiatry. In: Anxiety. In: Scully, J.H. (ed): Psychiatry. Philadelphia, Harwal Publishing Co. Harwal Publishing Co.
  • Dubovsky SL. (1988) Psychiatry. In: Substance related disorders. In: Scully, J.H. (ed): Psychiatry. Philadelphia, Harwal Publishing Co. Harwal Publishing Co.
  • Scully JH, Dubovsky SL. (1988) Medicine: Diagnosis and Treatment. In: Psychiatric disorders. In: Schrier, RW(ed): Medicine: Diagnosis and Treatment. Little Brown
  • Dubovsky SL. (1987) Textbook of Neuropsychiatry. In: Psychopharmacologic treatment in neuropsychiatry. In: Hales RE, Yudofsky S.C. (eds): Textbook of Neuropsychiatry. American Psychiatric Press, 663-701.
  • Dubovsky SL, Weissberg MP. (1986) Clinical Psychiatry in Primary Care (3rd Ed) (Also published in Spanish and Japanese). Williams and Wilkins.
  • Dubovsky SL. (1985) Understanding Human Behavior (3rd Ed). In: The psychophysiology of stress, illness and health. In: Simons RC (ed): Understanding Human Behavior (3rd Ed). Williams and Wilkins
  • Dubovsky SL. (1984) Surgical Decision Making (2nd Ed). In: The suicidal patient. In: Norton LW, Eiseman, B(eds): Surgical Decision Making (2nd Ed). Saunders
  • Dubovsky SL. (1984) The Interdisciplinary Rehabilitation of MS & Neuromuscular Disease. In: The therapist-patient relationship in chronic care. In: Maloney LP, Burks J, Ringel SP(eds): The Interdisciplinary Rehabilitation of MS & Neuromuscular Disease. Lippincott
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: The threatening or frightening patient. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL, Feiger A, Eiseman B (Eds). (1984) Psychiatric Decision Making. CV Mosby.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: New antidepressants. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL (Ed). (1984) Insight into Depression and Suicide: A Perspective for the Primary Care Physician. Healthscan, Inc..
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Lithium carbonate. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: First-line drugs used to treat depression. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Drug intoxication. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Couples therapy. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. St. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Chronic severe self-destructive behavior. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Acute drug and alcohol syndromes. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Sadness, unhappiness, misery. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Agitation. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Current Medical Therapy. In: Psychiatric and sexual disorders. In: Schrier RW(ed): Current Medical Therapy. Raven Press, 561-579.
  • Dubovsky SL. (1984) Psychiatric Decision Making. In: Second-line drugs used to treat depression. In: Dubovsky SL, Feiger A, Eiseman B (eds): Psychiatric Decision Making. CV Mosby Co.
  • Dubovsky SL. (1984) Care of the Injured--A Practical Guide. In: Acute psychiatric problems related to trauma. In: Eiseman B, Moore E, Van Way C (Eds): Care of the Injured--A Practical Guide. CV Mosby, 54-61.
  • Dubovsky SL. (1984) Principles of Family Medicine. In: The angry patient. In: Robertson D(ed): Principles of Family Medicine.
  • Dubovsky SL. (1983) Medical Problems During Pregnancy. In: Psychiatric approach to high risk obstetrics. In: Abrams R, Wexler P(eds): Medical Problems During Pregnancy. Little Brown
  • Dubovsky SL, Weissberg MB. (1982) Clinical Psychiatry in Primary Care: 2nd Edition. Williams and Wilkins.
  • Dubovsky SL. (1982) Psychological Management in Neurological Practice. Roche Products, Inc..
  • Dubovsky SL. (1982) Psychiatric Problems in Neurological Practice. Roche Products, Inc..
  • Dubovsky SL. (1981) Psychiatric Problems in Primary Practice (series of 6 monographs). Hoffman-La Roche Publications.
  • Dubovsky SL, Dilts SL. (1981) Psychological Management in Family Practice. Roche Products Inc..
  • Dubovsky SL (Ed). (1981) Psychological Management in Medical Practice (series of 6 monographs). Roche Products Inc..
  • Dubovsky SL. (1981) Understanding Human Behavior (2nd Ed). In: The psychophysiology of stress, illness and health. In: Simons RC, Pardes H(eds): Understanding Human Behavior (2nd Ed). Williams & Wilkins
  • Dubovsky SL, Dilts SL. (1981) Psychiatric Problems in Family Practice. Hoffman-LaRoche Publications.
  • Dubovsky SL. (1981) Psychotherapeutics in Primary Care. Grune and Stratton.
  • Dubovsky SL. (1980) Emotional Responses to Anesthesia and Surgery. In: Psychiatric considerations in transplant surgery. In: Guerra F, Aldrete JA(eds): Emotional Responses to Anesthesia and Surgery. Grune and Stratton
  • Dubovsky SL. (1980) Prognosis in Surgical Disease. In: Suicide. In: Eiseman B (Ed): Prognosis in Surgical Disease. Saunders
  • Dubovsky SL. (1978) Clinical Psychiatry in Primary Care. Williams and Wilkins.
  • Dubovsky SL. (1976) Topics in Family Practice. In: Current concepts in the differential diagnosis and treatment of depression. In: Cozzetto FC, Brettell HR (Eds.): Topics in Family Practice. Symposia Specialists
See all (69 more)

Abstracts:

  • Dubovsky SL. (2011) Review of The Risks of Prescription Drugs Edited by Douglas W Light. Am J Psychiatry. Am J Psychiatry, (Jan) 1124-1125
  • Boora K, Chiappone KL, Dubovsky SL. (2010) Ziprasidone-induced spontaneous orgasm. J Psychopharmacol, (Jan) 947-948
  • Dubovsky SL. (2009) Review of Philosophy of Psychopharmacology. Am. J. Psychiatry, (Jan) 834-835
  • Boora K, Chiappone K, Dubovsky SL. (2009) Oxcarbazepine-induced reversible anorgasmia and ejaculatory failure: a case report. Prim Care Companion J Clin Psychiatry, (Jan) 173-174
  • Dubovsky SL, Balon R. (2007) Leciva ve veku byznysui (Czech). Reflex, (Jan)
  • Dubovsky SL. (2006) Review of What Your Patients Need to Know About Psychiatric Medications. Am J Psychiatry, (Jan) 166
  • Dubovsky SL. (2000) Weight loss medications: more lost than gained. Journal Watch for Psychiatry, (Jan) 91-92
  • Dubovsky SL. (1998) Recurrence of lamotrigine-associated rash with rechallenge (ltr). J. Clin. Psychiatry, (Jan) 87
  • Dubovsky SL. (1998) Balancing the risks and benefits of clinical consultations on the Internet. Psych News International, (Jan)
  • Dubovsky SL, Buzan R. (1996) A psychopharmacologist’s view of anxiety and depression in the medically ill. Medical Psychiatry Forum June, (Jan) 11-15
  • Dubovsky SL, Piggott TA, Thase ME. (1995) Psychopharmacotherapy of refractory disorders. American College of Psychiatrists, (Jan)
  • Dubovsky SL. (1991) Recognition and Treatment of Psychotic Depression. New York, Guilford Press, (Jan)
  • Dubovsky SL. (1991) The scientific method can be applied to clinical psychiatry. Psychiatric Times, (Jan) 12-15
  • Dubovsky SL, Dunner DL, Eaton JS. (1990) Psychotic depressions. American College of Psychiatrists, (Jan) 1-10
  • Dubovsky SL. (1989) Psychopharmacology: Prospects for the '90s. Psychiatric Times, (Jan) 47-48
  • Dubovsky SL. (1988) Calcium channel blocking agents potentially useful in psychiatry. Psychiatric Times, (Jan) 17-19
  • Dubovsky SL, Ostergaard DJ, Strain JJ, Talley JH. (1980) A Review of How Primary Care Physicians and Psychiatrists Can Work Together in Managing Emotional Disorders. (Jan)
See all (7 more)

Professional Memberships:
  • Erie County Sheriff's Office (2016–present)
  • Amherst Technical Rescue Team (2009–present)
  • Distinguished Life Fellow, American Psychiatric Association (2009–present)
  • Fellow, American College of Psychiatrists (2006–present)
  • Eggertsville Firemen’s Benevolent Association (2005–present)
  • Eggertsville Hose Company (2005–present)
  • Distinguished Fellow, American Psychiatric Association (1993–2009)
  • Fellow, American Psychiatric Association (1983–1993)
  • American College of Psychiatrists (1982–present)
  • Group for Advancement of Psychiatry (1975–present)
  • Colorado Foundation for Medical Care (1973–2004)
  • Colorado Psychiatric Society (1973–2004)
  • American Psychiatric Association (1973–present)
See all (3 more)

Presentations:
  • "New Psychiatric Treatments" Comprehensive Review of Psychiatry (2022)
  • "Management of violence" Comprehensive Review of Psychiatry (2021)
  • "Psychiatric Management in Primary Care. Boston University (Zoom). March-June 2021" (2021)
  • "Advances in the theory and practice of biological psychiatry" Boston University (2020)
  • "Mind, Body and Medicine" Association of Asian-American Physicians, Buffalo, NY (2017)
  • "Ni, J., Yuan J., Chen, T., Helm, M., Li, A., Dubovsky S.L., Xu J: Association study of polymorphisms of the neuregulin 1 (NRG1) gene with schizophrenia" World Congress of Psychiatric Genetics, Orlando, FL (2017)
  • "Diagnosis and Management of Patients with Co-Occurring Substance Abuse and Other Psychiatric Disorders. Comprehensive Review of Psychiatry" Annual Comprehensive Review of Psychiatry, Niagara Falls, NY (2017)
  • "Xu, J., Yao, B., Liu, C., Zhang, L., Wang S., Helm M., Xu, H., Li, A., Dubovsky SL: The polymorphisms of GluR6 kainate receptor gene GRIK2 association with schizophrenia" International Convention of Psychological Science, Vienna (2017)
  • "The Theory and Practice of Biological Psychiatry" New England Educational Institute. Marco Island, Florida (2017)
  • "The Real Story of Depression" Mini Med School, University at Buffalo (2016)
  • "Biological and Psychological Consequences of Human Trafficking" Buffalo State College (2016)
  • "Bipolar Depression: Mechanisms and Treatment Principles" Beth Israel Hospital Department of Psychiatry. New York, NY (2016)
  • "New Treatments in Psychiatry: Are We There Yet?" Comprehensive Review of Psychiatry, Buffalo, NY (2016)
  • "New Developments in Somatic Therapies in Psychiatry" New England Educational Institute. Marco Island, Florida (2016)
  • "New Psychiatric Treatments- Is Anything New?" University at Buffalo - Neurology (2016)
  • "Under Utilized Psychiatric Treatments" Institute on Psychiatric Services. New York, NY (2015)
  • "Genetic Testing in Psychiatry" Comprehensive Review of Psychiatry, Niagara Falls, NY (2015)
  • "What’s Up With New Psychiatric Medications?" Roswell Park Medical Club, Buffalo, NY (2015)
  • "PTSD - Keynote Address" Institute for Community Health Promotion, Buffalo State (2014)
  • "Recent Developments in Psychiatric Treatments" Tenth Annual Comprehensive Review of Psychiatry, Niagara Falls, NY (2014)
  • "What Do We Know About the Neurobiology of Mood Disorders?" Western NY Psychiatric Association. Buffalo, NY (2014)
  • "Practical Approaches to the Management of Medication Side Effects" Comprehensive Review of Psychiatry, Niagara Falls, NY (2013)
  • "Problems with the New York SAFE Act. Mental Health Legal Services" White Plains, NY (2013)
  • "New Developments in Psychopharmacology and Instrumental Therapies" New England Educational Institute. Marco Island, Florida (2013)
  • "Novel Bipolar Therapies and the Pathophysiology of Bipolar Disorder" Northern California Psychiatric Society, San Francisco (2012)
  • "Laboratory Testing in Psychiatry" Comprehensive Review of Psychiatry, Niagara Falls, NY (2012)
  • "The Difficult Patient in Medical Practice" CME Distinguished Speaker. Mercy Hospital, Buffalo (2012)
  • "Understanding Post Traumatic Stress Disorder" University at Buffalo, University Express Lifelong Learning, Buffalo (2012)
  • "Diagnosis and Treatment of Bipolar Disorder" Southern Tier Environments for Living, Chautauqua, NY (2012)
  • "Treatments for Depression" American Neuropsychiatric Association. New Orleans (2012)
  • "Underutilized Psychotropic Drugs" New York University School of Medicine (2011)
  • "Underutilized and Over-Utilized Therapies in Psychiatry" Seventh Annual Comprehensive Review Of Psychiatry (2011)
  • "New Concepts in the Diagnosis, Pathophysiology and Treatment of Bipolar Disorder" Philippine Psychiatrists in America (2011)
  • "Advances in Psychopharmacology and Instrumental Therapies" New England Educational Institute (2011)
  • "Real Psychopharmacology: Facing Common Dilemmas in a Case-Based Open Format" New York University School of Medicine (2011)
  • "Mise à Jour Psychopharmacologique en Pédopsychiatrie" Association des Médecins Psychiatres du Québec (2010)
  • "Herbal and Complementary Therapies" Sixth Annual Comprehensive Review of Psychiatry (2010)
  • "Seasonal Affective Disorder" Citywide Medicine Grand Rounds (2010)
  • "What the hypertension specialist needs to know about anxiety and depression" American Society of Hypertension Scientific Meeting; American Society of Hypertension Scientific Meeting (2010)
  • "Recent Advances in the Conceptualization and Treatment of Alzheimer’s Disease" Rome GeneralHospital (2009)
  • "Assessment and Management of Insomnia" Central New York Psychiatric Center (2009)
  • "Assessment and Management of Rapid Cycling." American Academy of Clinical Psychiatrists (2009)
  • "Pathophysiology and Treatment of Progression in Bipolar Mood Disorders" Cornell University. (2009)
  • "Assessment and Treatment of Depression During Pregnancy and Postpartum" Buffalo Gynecologic And Obstetric Society (2009)
  • "Diagnosis and Treatment of Dementia" Department of Medicine Grand Rounds Buffalo General Hospital and Erie County Medical Center (2008)
  • "Diagnosis and Management of Insomnia" Fourth Annual Comprehensive Review of Psychiatry (2008)
  • "New Treatments for Bipolar Mood Disorders" First Annual Chair’s Summit (2008)
  • "Advances in the Treatment of Dementia Not Caused by Alzheimer‘s disease" American Psychiatric Association (2008)
  • "Neurobiology and Treatment of Deterioration of Bipolar Disorder" University of Massachusetts (2008)
  • "Advances in Bipolar Therapeutics" University of Wisconsin (2007)
  • "New Psychiatric Therapies and Approaches to Nonadherence" Third Annual Comprehensive Review of Psychiatry (2007)
  • "Presentation and Treatment of Depression with Medical Illness" World PsychiatricAssociation Seoul, Korea and Sydney (2007)
  • "Advances in Antipsychotic Drugs" Buffalo General Hospital and Sister’s Hospital Grand Rounds (2007)
  • "Pathophysiology of Deterioration of Bipolar Mood Disorders and Its Treatment." South Carolina Psychiatric Society (2007)
  • "Preventing Deterioration in Bipolar Mood Disorders" University of New Mexico (2006)
  • "Integrating Psychotherapy and Psychopharmacology" Second Annual Comprehensive Review of Psychiatry (2006)
  • "Mind Body Interactions in Mood Disorders" Scientific Expert Meeting (2006)
  • "Psychiatric Decision Making" Invitational Symposium on Diffusion, Adoption and Maintenance of Psychiatric Treatment Algorithms (2006)
  • "Toward a New Neurobiology of Mood Disorders" Medical University of South Carolina (2005)
  • "The Future of Psychiatric Therapies" Erie County Mental Health Association (2005)
  • "Critical Review of Treatments for Bipolar Disorder" Saint Joseph’s Hospital (2005)
  • "Second Messenger Signaling in Mood Disorders" Department of Psychiatry, Syracuse University (2005)
  • "Rational and Irrational Pediatric Psychopharmacology" Invisible Child Conference (2005)
  • "Schizophrenia: A Historical Perspective" Western New York Psychiatric Society (2005)
  • "Update on the Department of Psychiatry" Erie County Chapter, National Alliance for the Mentally Ill (2004)
  • "Advances in Bipolar Therapeutics" Colorado West Regional Mental Health (2004)
  • "Teaching Psychopharmacology: Who, When, Where?" University of South Florida (2004)
  • "Advanced Topics in Antipsychotic Drugs" Colorado Department of Corrections (2004)
  • "Anticonvulsants in Bipolar Disorder; Neurobiology of Mood Disorders: Fact and Fiction About Antipsychotic Drugs" Oklahoma Psychiatric Physicians Association (2004)
  • "New Developments in the Neurobiology of Mood Disorders" Mayo Clinic (2004)
  • "What’s New in the Treatment of Bipolar Disorder?" Rocky Mountain College (2004)
  • "Alzheimer‘s Disease and Other Dementias" Lawrence & Memorial Hospital (2004)
  • "A Clinician’s Guide to Psychiatric Research" New York University School of Medicine (2004)
  • "What’s New in Psychiatry?" Kalispell Regional Medical Center (2004)
  • "Identification and Treatment of Bipolar Disorder in Primary Care" St. Patrick’s Hospital (2003)
  • "What’s New in Bipolar Theraeputics?" Montana Mental Health Association (2003)
  • "Bipolar Disorder in Primary Care" Family Practice Review (2003)
  • "Comorbidity in Substance Use Disorders" Third Annual NIDA Blending Conference (2003)
  • "Diagnosis and Treatment of Bipolar Disorder in Primary Care Practice" Community Mental Health and Substance Abuse Partnership (2003)
  • "Does Early Treatment Prevent the Onset of Disorders of Arousal?" Dynamic Psychotherapy Conference (2003)
  • "Toward a New Psychobiology of Bipolar Disorder" University at Buffalo (2003)
  • "Best of the APA 2003." Colorado West Regional Mental Health Center (2003)
  • "PTSD Since 9/11" Internal Medicine Review (2003)
  • "Treatment of Depression in the Elderly" Internal Medicine Review (2003)
  • "Update on Bipolar Disorder" Family Practice Review (2003)
  • "Targeting Antidepressant Therapy to Medical Comorbidity" American Psychiatric Association (2003)
  • "Affect Regulation and Dysregulation" University of New Mexico (2003)
  • "Understanding Bipolar Disorder. Boulder Depression and Bipolar Support Association" Boulder (2003)
  • "Diagnosis and Treatment of Depression in Women" OBGYN Review (2003)
  • "Selected Topics in the Psychopharmacology of Women" Medical Education Resources (2003)
  • "Neurobiology of Schizophrenia and Its Treatment" Tulane University and Louisiana State University (2002)
  • "Intracellular Signaling in Mood Disorders." University of Miami Department of Psychiatry (2002)
  • "Introduction to Atypical Antipsychotic Medications" Northeast Florida State Hospital (2002)
  • "Affect Regulation Through the Life Cycle" Dynamic Psychotherapy (2002)
  • "Bipolar Illness in Medical Practice" Internal Medicine Review (2002)
  • "Mortality of Substance Abuse" American Council of Life Insurers, Medical Section (2002)
  • "Physician Stress and Burnout" 48th Family Practice Review (2002)
  • "Anxiety and Depression: Etiologic and Therapeutic Overlap" University of Nebraska (2002)
  • "Issues in Evaluating Clinical Trials in Social Phobia" Second International Neuroscience Consultant Congress (2002)
  • "Treatment of Mood Disorders in Women" Medical Education Resources (2001)
  • "Approaches to the Treatment of Mania" University Of California, Davis (2001)
  • "Dealing with Burnout" Family Practice Review (2001)
  • "Evolution of Diagnosis and Course in Bipolar Mood Disorders" University Of California (2001)
  • "Management of Depression in Patients with Medical Illnesses" Institute On Psychiatric Services (2001)
  • "Understanding the Course of Mood Disorders" Aspen (2001)
  • "Mind-Body Interactions in Mood Disorders" Mayo Clinic (2001)
  • "Psychopharmacology Update" Internal Medicine Review (2001)
  • "Combining Medications and Psychotherapy" Boulder Community Hospital Grand Rounds (2001)
  • "Depression in Children and Adolescents" Colorado Association of School Nurses (2001)
  • "Review of Atypical Antipsychotic Drugs" University of Utah (2001)
  • "Principles of Psychopharmacology in the Geriatric Patient" Menninger Foundation (2001)
  • "Neurobiology and Treatment of Refractory Mood Disorders" University of New Mexico (2001)
  • "Rational Polypharmacy" Southern Colorado Veterans Administration (2001)
  • "Treatment of Refractory Anxiety Disorders" Colorado Psychiatric Society (2001)
  • "Diagnosis and Treatment of Refractory Anxiety Disorders" Colorado Psychiatric Society Winter Meeting (2001)
  • "New Concepts in the Pathophysiology and Treatment of Mood Disorders" University of Arizona School of Pharmacy (2000)
  • "Neurobiology and Treatment of Refractory Mood Disorders" Aspen (2000)
  • "Rational Use of Antidepressants" Family Practice Review (2000)
  • "What’s New in Psychotherapeutic Drugs?" Family Practice Review (2000)
  • "Diagnosing and Treating Violence in Children" Colorado School Nurses Association (2000)
  • "Medications for Alzheimer‘s disease" Colorado Alzheimer’s Association (2000)
  • "Mind, Body and Mood" University of New Mexico Department of Psychiatry. (2000)
  • "Neurobiology of Schizophrenia and Depression" Neuroscience Advisory Group (2000)
  • "Treatment of Refractory Schizophrenia" University of California/Davis Department of Psychiatry (2000)
  • "Mind-Body Interactions in Mood Disorders" Colorado Psychiatric Society Winter Meeting (2000)
  • "New Medications for Depression and Bipolar Disorder" Colorado Psychiatric Society Winter Meeting (2000)
  • "New Treatments for Bipolar Disorder" Good Samaritan Hospital Department of Psychiatry (2000)
  • "Assessment and Treatment of Depression in Bipolar Patients" West Slope Casa (1999)
  • "Somatoform Disorders" University of Utah College of Pharmacy (1999)
  • "Treatment Options for Anxious Patients and Approaches to Refractory Anxiety" Menninger Clinic (1999)
  • "Use of Antidepressants in Primary Care" Western Regional Medical Center (1999)
  • "Antidepressant Side Effects and Interactions" Colorado Springs Psychiatric Society (1999)
  • "Mind-Body Interactions in Mood Disorders" 25th Annual Dynamic Psychotherapy Conference (1999)
  • "Psychiatric Update" Internal Medicine Review (1999)
  • "Treatment of Depression in Women" Medical Education Resources (1999)
  • "Causes and Treatment of Burnout" Family Medicine Review (1999)
  • "Crisis Therapy: Psychological and Pharmacologic Principles." Ontario Crisis Workers Society (1999)
  • "Rational and Irrational Polypharmacy, and Treatment Resistant Psychotic Disorders." Tulane University Department of Psychiatry (1999)
  • "Refractory and Bipolar Depression." Queens University (1999)
  • "Second Messengers in Mood Disorders (Research day keynote address)" Queens University (1999)
  • "New Treatments for Mood and Anxiety Disorders" University of California at Davis Department of Psychiatry (1999)
  • "Treatment Strategies in Refractory Depression" Colorado Mental Health Institute (1999)
  • "Diagnosis and Treatment of Impulsivity in Various Settings" Boulder Community Hospital (1999)
  • "Crisis Management: Assessment and Treatment Principles" Mt. Sinai Hospital (1998)
  • "New Antidepressants on the Horizon" Oshawa General Hospital- Psychopharmacology (1998)
  • "Diagnosis and Treatment of Depression in Men" Tulan University School of Medicine (1998)
  • "Diagnosis and Treatment of Alzheimer’s Disease and Depression in the Elderly" Sunset Nursing Home (1998)
  • "Treatment of Bipolar Disorder in Primary Care Practice" Internal Medicine Review (1998)
  • "Treatment of Problem Behaviors in Demented Patients" Internal Medicine Review (1998)
  • "Treatment of Refractory Obsessive Compulsive Disorder" Orange County (1998)
  • "Advanced psychobiology of dissociation" Colorado Society for the Study of Dissociation (1998)
  • "Management of difficult patients" Colorado Mental Health Institute at Pueblo. (1998)
  • "Medication combinations in refractory mood disorders" Colorado Springs Psychiatric Society (1998)
  • "Diagnosis and Treatment of Dementia" St. Anthony’s Hospital (1998)
  • "Targeted Treatment of Depression" American Academy of Neurology (1998)
  • "Refractory Depression." University of California at Davis (1998)
  • "Treatment of Obsessive Compulsive Disorder with Psychotic Symptoms" Orange County Mental Health Services (1998)
  • "Update on New Treatments for Depression and Anxiety" University of Colorado Health Sciences Center (1998)
  • "Intracellular Calcium Ion Disturbances in Bipolar Mood Disorders" American College of Neuropsychopharmacology (1997)
  • "Treatment of Complex Bipolar Disorder" Colorado Mental Health Institute at Fort Logan (1997)
  • "Psychotic Depression: Conceptualizations" III Congreso Mundial de Estados (1997)
  • "Integration of Psychotherapy and Pharmacotherapy in the treatment of the difficult patient" 22nd Conference on Dynamic Psychotherapy (1997)
  • "Mind-Body Deceptions" Aurora Mental Health Center (1997)
  • "Update on Anxiety and Panic" San Francisco (1997)
  • "Antidepressants in General Medical Practice: Which Ones, How Long?" Internal Medicine Review (1997)
  • "Mind-Body Deceptions" University of Denver (1997)
  • "Use of New Antidepressants" University of Alabama Department of Psychiatry (1997)
  • "Bipolar Disorder" Western Slope Regional Mental Health Center (1997)
  • "How to Do Research" University of Manitoba Department of Psychiatry (1997)
  • "Translation of Experience into the Psychobiology of Abnormal Mood" North York General Hospital (1997)
  • "Hamilton Ford Lecture: Update on Pharmacotherapy in Geriatric" 37th Titus Harris Society Annual Meeting; Universityof Texas Medical Branch (1997)
  • "Avoiding Legal Pitfalls in the Treatment of Violent Patients" American College of Psychiatrists (1997)
  • "Overview of New Antidepressants" Texas Academy of Family Physicians (1997)
  • "Treatment of Depression in Patients with Bipolar Mood Disorder" Poudre Valley Hospital (1996)
  • "New Approaches to Managing Refractory Depression" Canadian Psychiatric Association (1996)
  • "Approaches to Refractory Mood Disorders" West Slope Casa (1996)
  • "Psychopharmacology in the Older Patient" Ohio State University (1996)
  • "Management of Partial and Non-Response to Antidepressants" X World Congress of Psychiatry (1996)
  • "Avoiding and Managing Burnout" Family Practice Review (1996)
  • "Understanding and Using New Antidepressants" Portage Path Mental Health Center (1996)
  • "Rational Development of Serotonergic Medications" University of Manitoba (1996)
  • "Clinical Implications of Serotonergic Mechanisms" Sunnybrook Health Sciences Centre (1996)
  • "Depression in Bipolar Disorder: Recent Approaches" St. Elizabeth Health Center (1996)
  • "Potential Benefits of Specific Agents in Psychiatric Disorders." Whitby Mental Health Centre (1996)
  • "Issues in Psychopharmacology in Women Patients" University of California at Davis (1996)
  • "The Cytochrome P450 System" North Pacific Society of Neurology, Neurosurgery and Psychiatry (1996)
  • "Approaches to Refractory Obsessive Compulsive Disorder" Colorado Springs Psychiatric Society (1996)
  • "Ethical and Clinical Issues in Managed Care" American College of Psychiatrists (1996)
  • "Management of Refractory Bipolar Disorder" Aurora Mental Health Center (1996)
  • "Serotonin Reuptake Inhibitors in the Treatment of Depression and Impulsivity" Memorial Hospital (1996)
  • "Advances in theory and practice of serotonergic agents" Akron General Hospital (1996)
  • "Assessing Personality in Bipolar Patients" Colorado Psychiatric Society (1996)
  • "Overview of the Management of Refractory Depression" Quebec (1996)
  • "Management of Dysthymia Complicated by Major Depression" Institute on Psychiatric Services (1995)
  • "Mind, Mood and Medicine" University of Colorado (1995)
  • "Psychopharmacology in Brief Therapy" University of New Mexico (1995)
  • "Psychopharmacology of Refractory Disorders" University of Western Ontario/Stratford General Hospital (1995)
  • "Integrating psychotherapy and psychopharmacology" University of South Carolina Department of Psychiatry (1995)
  • "Overview of new treatments for depression." University of Alabama Department of Psychiatry (1995)
  • "Selected Topics in the Psychopharmacology of Women" Dynamic Psychotherapy Conference (1995)
  • "Managing the Somatizing Patient and New Serotonergic Antidepressants" Internal Medicine Review (1995)
  • "Managing Mental Disorders in Primary Care Practice" University of Colorado Health Sciences Center Primary Care Course (1995)
  • "New Treatments for Depression" Medical Grand Rounds; Fairview General Hospital (1995)
  • "Overview of Obsessive Compulsive Disorder" Mountain Crest Hospital (1995)
  • "The Relationship Between Adolescent Bipolar Illness and ADHD" Belmont Pines Hospital (1995)
  • "Treatment of Major Depression Complicated by Dysthymia" American Psychiatric Association (1995)
  • "Approaches to Treatment Resistant Depression in a Managed Care Environment" Boulder (1995)
  • "Intracellular Calcium Mechanisms in Affective Disorders" Hinz VA Medical Center. (1995)
  • "New Antidepressants" Lutheran Hospital (1995)
  • "Treating Refractory Depression in a Managed Care Environment" California Pacific Medical Center (1995)
  • "Changes in Mood and Anxiety Disorders from DSM-III-R to DSM-IV" Colorado State Mental Health Institute (1994)
  • "Electroconvulsive Therapy" New York University School of Medicine (1994)
  • "Interaction of Anxiety and Depression and New Treatments for GAD and Panic Disorder. Advances in Treating Anxiety Disorders" Atlanta (1994)
  • "Management of Acutely and Chronically Suicidal Patients" Witchita Falls State Hospital (1994)
  • "Approaches to Treatment Resistant Mood Disorders" Tennessee Psychiatric Society (1994)
  • "New Psychiatric Medications on the Horizon" Los Alamos National Laboratory (1994)
  • "Pharmacology of Refractory Disorders." U.S. Psychiatric Congress (1994)
  • "Current Concepts in the Treatment of Anxiety" University of South Carolina Department of Psychiatry (1994)
  • "Understanding and Treating the Interaction Between Affect and Psychosis" University North Pavillion Seminar (1994)
  • "Combining Psychopharmacology and Psychotherapy" Dynamic Psychotherapy Conference (1994)
  • "Diagnosis and Management of Psychotic Depression and Approaches to Treatment Resistant depression" Menninger Foundation (1994)
  • "A New Generation of Serotonin Selective Agents" American Psychiatric Association (1994)
  • "Manic Depressive Illness" Boulder Mental Health Center (1994)
  • "Treatment of Anxiety and Psychosis in the Elderly" Ochsner Foundation (1994)
  • "Approaches to Treatment Resistant Depression" Albany Medical College (1994)
  • "Management of Adolescent Mood Disorders" New York University School of Medicine Department of Psychiatry (1994)
  • "Nimodipine and Clinical Significance of 5HT2 Receptor Agonists and Antagonists" New York University School of Medicine (1994)
  • "Treatment of Geriatric Neuropsychiatric Conditions" Las Vegas (1994)
  • "Brain Systems Involved in Anxiety and Depression" Clarke Institute of Psychiatry and University of Ottowa (1993)
  • "New Selective Serotonergic Agents" U.S. Psychiatric Congress (1993)
  • "Update on Psychopharmacology (course)." Denver Institute for Psychoanalysis (1993)
  • "Dealing with Patients Who Don‘t Make You Feel Good (Panel moderator)" Colorado Medical Society (1993)
  • "Management of Refractory Psychotic Disorders" University of South Carolina (1993)
  • "Systems Implicated in Mood and Anxiety Disorders" Montreal (1993)
  • "Treatment Resistant Depression" Park Nicollett Medical Center (1993)
  • "The Psychobiology of PTSD and Its Treatment." Dynamic Psychotherapy Conference (1993)
  • "New Agents Acting on Serotonin" University of Oklahoma (1993)
  • "Recognizing Depression and Using New Antidepressants" St. Mary‘s Hospital (1993)
  • "Beyond the Serotonin Reuptake Inhibitors" American Psychiatric Association (1993)
  • "Involvement of Serotonin in Anxiety and Depression" Hospital Notre-Dame (1993)
  • "Link Between Neurobiology and Clinical Practice" Centre Hospitalier de l‘Universite Laval Quebec City (1993)
  • "New Medications Acting on Serotonin" Nova Scotia Hospital (1993)
  • "Recent Developments in Antidepressant Medicines, Treatment of Impulsive and Violent Patients, Diagnosis and Treatment of Psychotic Depression, and Treatment of Resistant Depression" Kansas Institute (1993)
  • "Overcoming Sever Treatment Resistance, Recognizing Psychotic Depression, Better Management of Self-Destructive Behavior, and Controversies in Mood Disorders" St. Martin, French Antilles (1993)
  • "Treatment of Anxiety Disorders and Treatment of Psychotic Depression." Menninger Clinic (1993)
  • "New Trends in Psychopharmacology." Camelback Samaritan Behavioral Health Services (1993)
  • "Recent Developments in the Treatment of Bipolar Disorder" Bethesda Hospital (1993)
  • "The Costs and Benefits of Modern Mental Health Care" Colorado State Legislature (1993)
  • "Treatment of Subtypes of Depression (with A. John Rush) and Treatment of Psychotic Depression (with Alan Schatzberg)." American College of Psychiatrists (1993)
  • "Calcium Antagonists for Manic Depressive Disorder" University of Freiburg Symposium on Anticonvulsants in Psychiatry (1993)
  • "Strategies for Selecting Anxiolytic Medications" California Pacific Medical Center (1993)
  • "Biology of Unusual and Very Difficult Psychoses" U.S. Psychiatric Congress (1992)
  • "The Psychobiology of Treatment Resistance" U.S. Psychiatric Congress. (1992)
  • "Management of Treatment Refractory Mood Disorders" University of South Carolina School of Medicine (1992)
  • "Practical Neurobiology of Anxiety and Panic" LaJolla (1992)
  • "Application of 5HT1A Partial Agonists in the Treatment of Depression" Montreal (1992)
  • "Approaches to the Treatment of Depression in Anxious Patients" University of Alabama (1992)
  • "Pharmacotherapy with Difficult Patients" Conference on Solution- Focused Therapy and Ericksonian Hypnosis for Adult Survivors Cedar Springs Hospital (1992)
  • "The Development of New Medications for Anxiety and Depression" California Pacific Medical Center (1992)
  • "Diagnosis and Treatment of Insomnia" Grand Junction Community Hospital (1992)
  • "New Treatments Under Development for Anxiety and Depression" Centennial Peaks Hospital (1992)
  • "Controversies in the Treatment of Depression" Internal Medicine Review (1992)
  • "Mind, Mood and Medicine" Given Institute (1992)
  • "An Update on the Genetics of Mental Illness" Newport Beach (1992)
  • "Diagnosis and Treatment of Sleep Disorders" Deaconness Hospital (1992)
  • "New Treatments on the Horizon for Anxiety and Depression" American Psychiatric Association (1992)
  • "The Psychosomatics of Everyday Life. Smithsonian Institution" Resident Associate Program (1992)
  • "New Treatment Approaches for Depression" Colorado State Hospital (1992)
  • "New Treatment Approaches to Anxiety for Psychiatrists and Primary Care Physicians" Vancouver and Victoria, B.C., (1992)
  • "Course in Psychopharmacology" Kaiser Foundation Department of Psychiatry (1992)
  • "Depression in Children and Adolescents and Techniques for Managing Behavioral Disturbances in the Classroom" Fifth Collaborative Conference for Special Education (1992)
  • "Treatment Resistant Panic Disorder" California Pacific Medical Center (1992)
  • "Better Recognition of Organic Brain Syndromes" Fourth U.S. Psychiatric Congress (1991)
  • "Psychopharmacology for Neurological Patients." Fourth U.S. Psychiatric Congress (1991)
  • "New Approaches to the Treatment of Anxiety" Suburban Hospital (1991)
  • "Psychopharmacologic Treatment of Depression and Anxiety Associated with Traumatic Brain Injury" Midwestern Head Injury Conference; Midwestern Head Injury Conference (1991)
  • "Recognition and Treatment of Depression" Avista Hospital (1991)
  • "Advances in the Diagnosis and Treatment of Psychotic Depression" McAuley Medical Center (1991)
  • "New Developments in the Psychobiology of Depression and Psychotic Depression" Aurora CMHC; Aurora CMHC (1991)
  • "New Concepts in the Treatment of Depression" El Paso County Mental Health Association (1991)
  • "Recognition and Management of Organic Brain Syndromes" Porter Hospital (1991)
  • "Cell Biology and the Disease Concept in Psychiatry." Baylor University School of Medicine (1991)
  • "Second Messenger Dysfunction in Mood Disorders" University School of Medicine (1991)
  • "Integrating Mind, Body and Medicine in the Mental Health" Gold Medal Lecture; Mt Airy Foundation (National Selection) (1991)
  • "Recognition and Treatment of Depression" Oregon Academy of Family Psysicians (1991)
  • "Why Psychiatrists Need to Know About Second Messengers." Distinguished Lecture Series, Northwestern University (1991)
  • "Advances in the Conceptualization and Treatment of Bipolar Illness" University of Miami (1991)
  • "Advances in the Psychobiology of Depression" Centennial Peaks Hospital Advances in Neurobiology Symposium (1991)
  • "Better Recognition of Organic Brain Syndromes" Third U.S. Psychiatric Congress (1990)
  • "Cell Biology and Concepts of Disease" Third U.S. Psychiatric Congress (1990)
  • "New Directions in the Treatment of Anxiety" University of Kansas (1990)
  • "Treatment Resistant Depression" Pacific Presbyterian Medical Center (1990)
  • "New Treatments in Psychiatry" Colorado Psychiatric Society/Colorado Alliance for the Mentally Ill. (1990)
  • "Recurrent and Refractory Depression" Hospital Community Psychiatry Institute (1990)
  • "The Psychobiology of Treatment Resistance" Hospital Community Psychiatry Institute (1990)
  • "Introduction to Psychopharmacology (Course)" Denver Institute for Psychoanalysis (1990)
  • "New Approaches to Anxiety Disorders and Advances in Conceptualization and Treatment of Depression" Poudre Valley Hospital (1990)
  • "Psychopharmacology of the Future" XIV International Congress of Clinical Chemistry (1990)
  • "Depression and Character" West Pines Hospital (1990)
  • "Discussion of New Treatments for Mania." American Psychiatric Association (1990)
  • "Intracellular Calcium Ion Disturbances in Bipolar Disorders" American Psychiatric Association (1990)
  • "Treatment of Depression in Anxious Patients" American Psychiatric Association (1990)
  • "Advanced Psychopharmacology" Moscow and Leningrad (1989)
  • "Advanced Psychopharmacology Review" Kaiser Foundation Department of Psychiatry (1989)
  • "Diagnosis and Treatment of Anxiety Disorders" Humana Hospital (1989)
  • "Diagnosis and Treatment of Psychotic Depression" American Psychiatric Association (1989)
  • "Disturbances of Water Metabolism in Psychosis" American Psychiatric Association (1989)
  • "New Developments in Psychopharmacologic Management of Generalized Anxiety Disorder" American Psychiatric Association (1989)
  • "Treatment Resistant Depression" American Psychiatric Association (1989)
  • "Advances in Psychiatric Research" Boulder Alliance for the Mentally Ill (1989)
  • "Intracellular Calcium Ion Dynamics in Psychiatric Disorders" Cornell University School of Medicine (1989)
  • "Diagnosis and Treatment of Generalized Anxiety Disorder" Bethesda Hospital (1989)
  • "Sleep Disorders" Centennial Peaks Hospital (1988)
  • "Seasonal Affective Disorder" Mt. Airy Hospital (1988)
  • "Advanced Topics in Psychopharmacology (course)" American Psychiatric Association (1988)
  • "Diagnosis and Treatment of Psychotic Depression" American Psychiatric Association (1988)
  • "Entitlement in Surgical Education" St. Joseph Hospital (1988)
  • "Basic Topics in Psychopharmacology and Advanced Topics in Psychopharmacology" Boulder Community Hospital (1988)
  • "Entitlement in Medical Education" Association of American Medical Colleges (1987)
  • "Intracellular Calcium Dynamics in Affective Disorders" University of Kansas (1987)
  • "Tardive Dyskinesia, Pathophysiology and Treatment" Albany Medical College (1987)
  • "The Mental Status Examination" Lutheran Hospital (1987)
  • "A New Focus on Major Mental Illness" Colorado Alliance for the Mentally Ill (1987)
  • "Advanced Topics in Psychopharmacology (Course)" American Psychiatric Association (1987)
  • "Coping with Entitlement in Our Students, Our Residents, Our Patients and Ourselves" Clear Creek Medical Society (1987)
  • "Interaction of Biology and Psychology in Affective Disorders" Bethesda Hospital (1987)
  • "Advanced Psychopharmacology Review (course)" Bethesda Psychiatric Hospital (1986)
  • "Advanced Topics in Psychopharmacology (Course)" American Psychiatric Association (1986)
  • "Psychological Considerations in Chronic Disability" American Academy of Neurology (1986)
  • "Program Review in the Medical School" Association of American Medical Colleges (1986)
  • "The Brain (with Richard Restak, M.D.)." Boulder Psychiatric Institute (1986)
  • "Affect and the Development of Personality." Mt. Airy Hospital (1986)
  • "Psychopharmacology Review" Boulder Psychiatric Institute (1985)
  • "New Biological Concepts in Affective Disorders" Research Psychiatric Institute (1985)
  • "Alzheimer‘s Disease and Depression" Northern California Medical Society (1985)
  • "Intracellular Calcium in Affective Disorders" IV World Congress of Biological Psychiatry (1985)
  • "Dealing with the Treatment Resistant Patient" Fort Lyon VA Hospital (1985)
  • "Anxiety and Depression" Top 20 Problems in Family Medicine (1985)
  • "Psychiatric Aspects of Neurological Rehabilitation" American Academy of Neurology (1985)
  • "Diagnosis and Treatment of Organic Brain Syndromes" Baylor University College of Medicine (1985)
  • "Clinical Approach to Psychosomatic Medicine" Porter Hospital (1984)
  • "Psychiatry and the Primary Care Physician" New Jersey Academy of Family Physicians (1984)
  • "Discussion of H. Schlesinger: The Use of the Dream in Psychotherapy" Aspen (1984)
  • "Depression in the Elderly" Ohio Academy of Family Practice (1984)
  • "Liaison Psychiatry in the 1980‘s" Department of Psychiatry, University of Oregon School of Medicine (1984)
  • "Physician Impairment" Department of Medicine, Good Samaritan Hospital (1984)
  • "Overview: Treatment of Depression" Michigan Academy of Family Practice (1984)
  • "Psychiatric Considerations in Hepatic Transplantation" Cornell University Medical School (1984)
  • "Management of the Treatment Resistant Outpatient" San Mateo County Department of Health Services (1983)
  • "Management of the Chronically Suicidal Patient" Lyons V. A. Hospital (1983)
  • "Modern Concepts in the Management of Psychiatric Emergencies" New Mexico Medical Association (1983)
  • "Treatment-Resistant Depression in the Borderline Patient" McAuley Medical Center (1983)
  • "Nervous and Mental Disorders" Top 20 Problems in Family Medicine (1983)
  • "Differential Diagnosis in Psychiatry" Aurora Mental Health (1983)
  • "New Advances in Biological Psychiatry" University of New Mexico (1983)
  • "Treatment of the Borderline Patient" Pikes Peak Mental Health Center (1983)
  • "Management of Somatization and Chronic Depression" Hawaii Medical Association and Hawaii Pharmaceutical Association (1983)
  • "Psychiatry and Primary Care Practice" Michigan Academy of Family Practice (1983)
  • "Psychiatry and the Primary Care Physician" Indiana Academy of Family Physicians, (1983)
  • "Psychosomatic Aspects of Heart Disease" Cancer and Mental Illness American Biofeedback Society (1983)
  • "Depression in Childhood and Adolescence and Depression in the Elderly." The Oregon Academy of Family Physicians (1983)
  • "Treatment of the Patient with Borderline Personality Disorder" Beth Israel Postgraduate Psychiatry Course (1983)
  • "New Approaches to the Treatment of Depression" Keessler AFB and Gulfport VA Hospital (1983)
  • "Advances in Biological Psychiatry" Western New York Psychiatric Association (1982)
  • "The Dean‘s Perspective on Administrative Use of Psychiatric Information" Association of American Medical Colleges (1982)
  • "New Biological Approaches to Depression" Utah Psychiatric Society (1982)
  • "Psychosocial Management in Cancer Therapy" Logan County Hospital Tumor Board (1982)
  • "Discussion of: Pitfalls in the Path of the Empathic Response by David Sachs" Aspen (1982)
  • "Current Concepts in the Diagnosis and Management of Depression" Rocky Mountain Hospital (1982)
  • "New Developments in the Diagnosis and Treatment of Depression" Indiana University School of Medicine (1982)
  • "Management of the Somatizing Patient" Lane County Medical Society (1982)
  • "Psychiatric Medicine Update 1982 - Diagnosis and Management of Depressive Illness" Sacred Heart General Hospital (1982)
  • "Evaluation and Treatment of the Suicidal Patient" San Luis Valley AHEC (1982)
  • "Violence A-Z" Eighth Annual Regional Meeting, American College of Emergency Physicians (1982)
  • "Hypochondriasis" Cheyenne Family Practice Center (1981)
  • "Forms of Endings of Psychotherapy" Aspen (1981)
  • "Initial Evaluation and Management of the Suicidal Patient" Medical Staff Foundation; Weld County General Hospital (1981)
  • "Problems in the Doctor-Patient Relationship" American Psychiatric Association Regional Meeting (1981)
  • "The Primary Care Physician‘s Role in Treating the Chronically Mentally Ill" American Medical Association Scientific Meeting (1981)
  • "Treatment Issues in Long-term Care" American Medical Association Scientific Meeting (1981)
  • "Differential Diagnosis of the Unexplained Somatic Complaint" Presbyterian Hospital Department of Medicine (1980)
  • "The Problem Patient in Internal Medicine" Presbyterian Hospital Department of Medicine (1980)
  • "What‘s New in Psychosomatic Medicine?" Bethesda Hospital (1980)
  • "The Schizophrenia-like Psychoses of Epilepsy" Mt. Airy Hospital (1980)
  • "Working with the Surgeon and His Patient" American Psychiatric Association (1980)
  • "Current Trends in the Psychiatric Education of Medical Students" Bethesda Hospital (1980)
  • "Psychophysiologic Aspects of Recovery from Myocardial Infarction" Boulder Community Hospital (1980)
  • "Review of Psychosomatic Medicine (4 conferences)." Wardenberg Student Health Service (1980)
  • "Horizons of Surgery--Psychiatric Aspects of Surgical Therapy for Obesity" Vail (1980)
  • "The Problem Patient in Internal Medicine" Boulder Memorial Hospital (1980)
  • "Brain Damage" University of Denver Department of Psychology (1979)
  • "Your Emotions and Your Health" University of Denver Postgraduate (1979)
  • "Management of the Dying Patient and His Family" Vail Family Practice Conference (1979)
  • "Psychiatric Considerations in Transplant Surgery (with Thomas)" Aspen (1979)
  • "Personality Types in Medical Management" American Critical Care Nurses Association (1979)
  • "Current Status of Psychosomatic Medicine" Colorado Division of Mental Health (1978)
  • "Use and Abuse of Drugs in the Aging Patient" American Geriatrics Society (1978)
  • "Use of Psychotropic Medications in the Elderly" Colorado Annual Mental Health Conference (1978)
  • "Dynamic Psychotherapy: Diagnostic and Therapeutic Considerations of the Transference Relationship" Aspen (1978)
  • "Organic Brain Syndromes" Mt. Airy Hospital Speaker‘s Forum (1978)
  • "Workshop on Aging and Dementia" Loretto Heights College (1978)
  • "Practical Psychopharmacology" Colorado Nurses Association (1978)
  • "Consultation Approaches with Health Facilities and Resultant Benefits for Staff and Patients" American Orthopsychiatric Association (1978)
  • "Organic Brain Syndromes" Ft. Logan Mental Health Center (1978)
  • "Uses and Misuses of Psychotropic Drugs" Aurora Mental Health Center (1978)
  • "Drugs Used in the Treatment of Geriatric Patients" Seniors, Inc. (1978)
  • "Psychosomatic Medicine" Colorado Psychiatric Society (1978)
  • "Organic Brain Syndromes" Colorado State Hospital (1977)
  • "Psychiatric Differential Diagnosis" Aurora Mental Health Center (1977)
  • "Psychological Reactions to Critical Illness" Colorado Heart Association (1977)
  • "A Death in the Family" Colorado Association for Continuing Medical Laboratory Education (1977)
  • "Evaluation of Outcome (Presentation), and Brief Psychotherapy" The Widening Scope of Dynamic Psychiatry (1977)
  • "Schizophrenia: Diagnosis and Treatment" Aurora Mental Health Center (1977)
  • "Recognition and Treatment of Borderline Symptomatology" Aurora Mental Health Center (1977)
  • "Psychiatric Aspects of Cardiovascular Disease" General Rose Hospital Denver (1977)
  • "Borderline Syndromes" Arapahoe Mental Health Center (1977)
  • "Organic Brain Syndromes" Aurora Mental Health Center (1977)
  • "Psychopharmacology in the Elderly" Davis Institute State-wide Conference on Aging (1977)
  • "Reduction in Mortality following Psychiatric Consultation" Colorado Psychiatric Society (1976)
  • "Heart Attack: What Now" Colorado Heart Association (1975)
  • "Psychological Aspects of Heart Disease" Colorado Heart Association (1975)
  • "Death and Dying and the Grief Process" Colorado Nursing Association (1975)
  • "The Role of Sensation in Human Development" Colorado Psychiatric Society (1974)
  • "Emotional Reactions to Terminal Illness" American Ostomy Association (1974)
  • "Numerous Grand Rounds to Departments of Medicine" Surgery, OB-Gyn, Neurology, Otolaryngology, Social Work, and School of Nursing (1974)
  • "Uses of Hypnosis in Mental Health Treatment" Indian Health Service (1973)
  • "Death and Dying" American Medical Center at Denver (1973)
See all (417 more)

Service Activities:
  • Psychotherapy and Psychosomatics; Editorial board member (2022–present)
  • Netherlands Organisation for Scientific Research; Reviewer (2022–2023)
  • Up to Date; Regular reviewer (2021–present)
  • Br J Psychiatry; Reviewer (2021–present)
  • J Psychiatr Res; Reviewer (2021–present)
  • Research for Health in Erie County; President (2019–present)
  • Pharmacogenomics; Reviewer (2019–present)
  • Research for Health in Erie County - Administer grant application for scientific and clinical research; President (2019–present)
  • Psychiatric Services; Reviewer (2019–present)
  • Expert Opinion on Pharmacotherapy; Reviewer (2018–present)
  • Chair, UB School of Medicine Conflict of Interest Committee; Chair (2018–present)
  • JSMBS Conflict of Interest Committee; Chair (2018–present)
  • International Task Force on Benzodiazepines; Member (2018–present)
  • Bipolar Disorders; Reviewer (2017–present)
  • Current Medical Research & Opinion; Reviewer (2017–present)
  • Br J Psychiatry; Reviewer (2016–present)
  • JAMA Psychiatry; Reviewer (2016–present)
  • Reserve deputy, Erie County Sheriff’s Office, Erie County, NY; Reserve Deputy (2015–present)
  • Neuropsychiatric Disease and Treatment; Reviewer (2015–present)
  • World Journal of Biological Psychiatry; Reviewer (2015–present)
  • Life Sciences; Reviewer (2015–present)
  • UBA Executive Committee (2014–present)
  • Legal Committee, Optimum Physicians Alliance (2013–present)
  • J Clin Psychiatry; Reviewer (2013–present)
  • Vice President, Research for Health in Erie County; Vice President (2011–2019)
  • Current Psychiatry; Consulting editor (2011–present)
  • European Journal of Psychiatry; Reviewer (2010–present)
  • Health Sciences IRB; Co-Chair (2010–2011)
  • Mind & Brain; Member (2010–present)
  • Journal of Clinical Psychopharmacology; Reviewer (2010–present)
  • Great Lakes Consolidation Committee for Psychiatry; Chair (2009–2010)
  • President, Management Council of UBMD (2008–2014)
  • Roswell Park Medical Club; Committee Member (2008–present)
  • Amherst Technical Rescue Team, Amherst NY; Rescue Team (2008–present)
  • Board of Directors, UB Associates (2007–2023)
  • Faculty Advisory Committee, Extreme Events Group. University at Buffalo (2007–2008)
  • Practice Plan Reorganization Committee, University at Buffalo; Chair (2007)
  • Promotions Criteria Revision Committee, University at Buffalo; Chair (2006–2007)
  • Prog Neuropsychopharmacol Biol Psychiatry; Reviewer (2005–present)
  • Board of Directors, Mental Health Association of Erie County (2005–2011)
  • Board of Directors, Erie County Mental Health Association (2005–2011)
  • Clinical Research Infrastructure Committee, University at Buffalo (2005)
  • Committee on Clinical Investigation and GCRC Planning, University at Buffalo; Chair (2005)
  • Board of Directors for Research for Health in Erie County; Board of Directors (2005–present)
  • Interior firefighter, Eggertsville Hose Company, Eggertsville, NY; Interior fifefighter (2005–present)
  • Chair; Executive Committee (2004–present)
  • President; UBMD Psychiatry (2004–present)
  • President of the Faculty, University of Colorado School of Medicine (2004–2005)
  • Research Review Committee; Chair (2004–present)
  • Neuropsychopharmacology; Reviewer (2004–present)
  • President-Elect of the Faculty, University of Colorado School of Medicine (2003–2004)
  • J Affective Disord; Reviewer (2001–present)
  • Bulletin of the Menninger Clinic; Consulting editor (1999–present)
  • Executive Committee, University Physicians, Inc. (1998–2002)
  • University Physicians Rules Revision Committee; Chair (1998)
  • Journal of Child & Adolescent Psychopharmacology; Reviewer (1998–present)
  • Psychiatry Research; Reviewer (1997–present)
  • Psychosomatic Medicine; Reviewer (1997–present)
  • Second Vice-President, University Physicians, Inc (1996–2002)
  • Management Committee (Board of Directors), University Physicians Inc. (1996–2001)
  • Journal Watch for Psychiatry; Associate editor (1994–2020)
  • Journal of Psychosomatic Research; Editorial board member (1994–present)
  • CNS Drugs; Reviewer (1994–present)
  • Drugs; Reviewer (1994–present)
  • Governing Board, Centennial Peaks Hospital (1993–1994)
  • Search Committee for Dean of the School of Medicine; Chair (1991)
  • Health Sciences Center Salary Equity Committee; Chair (1991)
  • Academic Psychiatry; Reviewer (1990–present)
  • President of the Faculty, University of Colorado School of Medicine (1989–1990)
  • Medical Scientist Training Program Coordinating Committee (1988–2004)
  • President-Elect of the Faculty, University of Colorado School of Medicine (1988–1989)
  • Executive Committee, Centennial Peaks Hospital, (1987–1989)
  • Education Committee, Centennial Peaks Hospital; Chair (1987–1989)
  • Tissue Committee, University Hospital (1986–1989)
  • Vice-President, University of Colorado Hospital Medical Board (1986–1989)
  • Faculty Evaluation Committee, Department of Psychiatry; Chair (1985–1999)
  • Residency Curriculum Committee, Department of Psychiatry (1985)
  • Psychoneuroendocrinology; Reviewer (1985–present)
  • University Physicians Incorporated (UPI) Committee, Department of Psychiatry (1984–1999)
  • Clinical Scholars Committee, Department of Medicine (1984–1985)
  • Dean's Review Committee, School of Nursing (1984–1985)
  • Committee on Junior Faculty, Department of Psychiatry; Chair (1984)
  • Biol Psychiatry; Reviewer (1984–present)
  • Executive Committee, Department of Psychiatry, (1982–1984)
  • General Hospital Psychiatry; Reviewer (1982–present)
  • Science; Reviewer (1982–present)
  • American Journal of Psychiatry; Reviewer (1982–present)
  • Search Committee for a Biomedical Ethicist (1981)
  • School of Medicine Medical Student Promotions Committee; Chair (1980–1982)
  • Medical Student Council (1979–1982)
  • Faculty Senate (1979–1990)
  • Executive Committee, School of Medicine (1979–1986)
  • Medical School Curriculum and Promotions Committee, lst and 2nd years (1979–1982)
  • Minority Student Affairs Committee (1979–1982)
  • Medical School Student Honors and Research Committee (1979–1982)
  • Financial Aid Policy and Appeal Subcommittee of the Educational Resources Policy Committee (EdRAC), (1979–1982)
  • Medical School Curriculum and Evaluation Committee (1979–1982)
  • Task Force on Educational Space Utilization and Management (1979)
  • Task Force on The Resident as Teacher (1979)
  • Continuing Education Committee, School of Medicine (1977–1980)
  • Faculty Council, University of Colorado Medical Center (1977–1979)
  • Medical School Curriculum and Promotions Committee, 3rd and 4th years; Chair (1977–1979)
  • Joint Curriculum Subcommittee (1977)
  • Human Research Committee, University of Colorado at Denver (1977)
  • Medical School Curriculum and Promotions Committee, 3rd and 4th years (1976–1977)
  • Chancellor's Task Force on Student Attitudes (1975)
  • Chairman's Task Force on Medical Student Education, Department of Psychiatry (1974–1975)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

University at Buffalo - Psychiatry
Erie County Medical Center
462 Grider St. Room 1168
Buffalo, New York 14215
Phone: 716-898-5940
Fax: 716-898-4538
dubovsky@buffalo.edu
View map

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD
Login to Update Your Profile